Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. You ...

Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. The ...

Axon Enterprise (AXON) has launched the Axon Body Workforce Mini, a body camera built for retail, healthcare, and other frontline sectors where incidents of workplace violence and theft have been ...

Axon Enterprise remains a Buy due to robust growth, innovative products, and strong revenue guidance despite a volatile share price and high valuation. AXON's new ABW Mini camera targets retail and ...

SCOTTSDALE, Ariz. - Axon (NASDAQ:AXON), the $55.65 billion security technology leader with impressive 60.58% gross margins, introduced a new, lighter body camera on Monday designed specifically for ...

Axon Enterprise Inc. (NASDAQ:AXON) is among the 9 Defense Stocks That Will Skyrocket. On September 29, JMP Securities analyst Trevor Walsh reiterated his Market Outperform rating for the stock and ...

When will Scottsdale voters get to weigh in on Axon’s plan for 1,900 apartments and a hotel in North Scottsdale? While the referendum is currently scheduled for November 2026, Mayor Lisa Borowsky and ...

The latest price target for Axon Enterprise (NASDAQ:AXON) was reported by JMP Securities on September 29, 2025. The analyst firm set a price target for $825.00 expecting AXON to rise to within 12 ...

A group staunchly opposed to Axon’s headquarters and housing project in north Scottsdale is suing the state over allegations that it gave the company special treatment and restricted voters’ rights, ...

ZTE Axon 40 Ultra Space Edition is officially announced on Nov. 29, 2022. The smartphone is powered by a Qualcomm SM8450 Snapdragon 8 Gen 1 octa-core processor while GPU is Adreno 730. It comes in a 6 ...

Medtech startup Axon Therapies has raised $32 million from investors to ramp up clinical trials for a new instrument to treat heart failure, the company announced. The Series A fundraise, led by ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...